Guardant Health Statistics

Total Valuation

Guardant Health has a market cap or net worth of MXN 210.42 billion. The enterprise value is 219.26 billion.

Market Cap	210.42B
Enterprise Value	219.26B

Important Dates

The last earnings date was Thursday, February 19, 2026.

Earnings Date	Feb 19, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	128.84M
Shares Outstanding	n/a
Shares Change (YoY)	+2.14%
Shares Change (QoQ)	+3.08%
Owned by Insiders (%)	3.68%
Owned by Institutions (%)	100.08%
Float	126.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.90
PB Ratio	-117.69
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-29.26
EV / Sales	12.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-52.26

Financial Position

The company has a current ratio of 4.84

Current Ratio	4.84
Quick Ratio	4.42
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-7.34
Interest Coverage	-111.96

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-15.59%
Return on Invested Capital (ROIC)	-19.43%
Return on Capital Employed (ROCE)	-25.50%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	7.08M
Profits Per Employee	-3.00M
Employee Count	2,506
Asset Turnover	0.56
Inventory Turnover	4.45

Taxes

Income Tax	-22.74M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +184.35% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+184.35%
50-Day Moving Average	1,192.34
200-Day Moving Average	n/a
Relative Strength Index (RSI)	74.22
Average Volume (20 Days)	1,039

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.20

Income Statement

In the last 12 months, Guardant Health had revenue of MXN 17.68 billion and -7.49 billion in losses. Loss per share was -59.78.

Revenue	17.68B
Gross Profit	11.40B
Operating Income	-7.85B
Pretax Income	-7.52B
Net Income	-7.49B
EBITDA	-7.14B
EBIT	-7.85B
Loss Per Share	-59.78

Full Income Statement

Balance Sheet

The company has 21.63 billion in cash and 30.79 billion in debt, giving a net cash position of -9.16 billion.

Cash & Cash Equivalents	21.63B
Total Debt	30.79B
Net Cash	-9.16B
Net Cash Per Share	n/a
Equity (Book Value)	-1.79B
Book Value Per Share	-13.69
Working Capital	20.94B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.33 billion and capital expenditures -869.66 million, giving a free cash flow of -4.20 billion.

Operating Cash Flow	-3.33B
Capital Expenditures	-869.66M
Free Cash Flow	-4.20B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 64.46%, with operating and profit margins of -44.43% and -42.39%.

Gross Margin	64.46%
Operating Margin	-44.43%
Pretax Margin	-42.52%
Profit Margin	-42.39%
EBITDA Margin	-40.38%
EBIT Margin	-44.43%
FCF Margin	n/a

Dividends & Yields

Guardant Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.14%
Shareholder Yield	-2.14%
Earnings Yield	-3.56%
FCF Yield	-1.99%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Guardant Health has an Altman Z-Score of 0.46 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.46
Piotroski F-Score	4